Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q1 EPS of ($3.16), $2.90 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.